Literature DB >> 14744664

A novel method to aerosolize powder for short inhalation exposures at high concentrations: isolated rat lungs exposed to respirable diesel soot.

Per Gerde1, Pär Ewing, Lena Låstbom, Ake Ryrfeldt, Juri Waher, Göran Lidén.   

Abstract

More efficient methods are needed to aerosolize dry powders for short-duration inhalation exposures at high concentrations. There is an increasing need to reach the peripheral lung with dry powder medications as well as with collected ambient aerosol particulates in environmental research projects. In a novel aerosol generator, a fixed volume of compressed air was used to create a short burst of a highly concentrated aerosol in a 300-ml holding chamber. Collected diesel soot was deagglomerated to a fine aerosol with a mass median aerodynamic diameter (MMAD) of 0.55 microm, not much larger than the 0.25 microm MMAD of diesel exhaust particles measured in air. A fine powder such as 3-microm silica particles was completely deagglomerated to an aerosol with a MMAD of 3.5 microm. Immediately after generation, the aerosol was available for exposure at a chosen flow rate by the use of an automated valve system. Tritium-labeled diesel soot was thus used to expose the isolated perfused rat lung at an air concentration of approximately 3 mg/L and a flow rate of 370 ml/min in a 1-min-long exposure. The lungs were ventilated at 75 breaths/min and a tidal volume of 1.13 +/- 0.11 ml (SD, n = 3). Results showed that 19.8 +/- 1.1 microg (SD, n = 3) soot was deposited in the lungs. This amount constitutes 9.5% of the amount inhaled and is close to literature data on deposition of similar sized particles in the rat lung. More than 97% of the deposited soot was located distal to the extrapulmonary bronchi, indicating that the system delivers a highly respirable aerosol. The aerosol system is particularly useful for peripheral lung delivery of collected ambient aerosols or dry powder pharmaceuticals following a minimal effort in formulation of the powder.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14744664     DOI: 10.1080/08958370490258381

Source DB:  PubMed          Journal:  Inhal Toxicol        ISSN: 0895-8378            Impact factor:   2.724


  6 in total

1.  Small particles disrupt postnatal airway development.

Authors:  DongYoub Lee; Chris Wallis; Anthony S Wexler; Edward S Schelegle; Laura S Van Winkle; Charles G Plopper; Michelle V Fanucchi; Ben Kumfer; Ian M Kennedy; Jackie K W Chan
Journal:  J Appl Physiol (1985)       Date:  2010-07-15

2.  Bioavailability of inhaled or ingested PFOA adsorbed to house dust.

Authors:  Åsa Gustafsson; Bei Wang; Per Gerde; Åke Bergman; Leo W Y Yeung
Journal:  Environ Sci Pollut Res Int       Date:  2022-06-14       Impact factor: 5.190

3.  Development of Combining of Human Bronchial Mucosa Models with XposeALI® for Exposure of Air Pollution Nanoparticles.

Authors:  Jie Ji; Anna Hedelin; Maria Malmlöf; Vadim Kessler; Gulaim Seisenbaeva; Per Gerde; Lena Palmberg
Journal:  PLoS One       Date:  2017-01-20       Impact factor: 3.240

4.  A Comparison of Drug Transport in Pulmonary Absorption Models: Isolated Perfused rat Lungs, Respiratory Epithelial Cell Lines and Primary Cell Culture.

Authors:  Cynthia Bosquillon; Michaela Madlova; Nilesh Patel; Nicola Clear; Ben Forbes
Journal:  Pharm Res       Date:  2017-09-18       Impact factor: 4.200

5.  A novel method for studying airway hyperresponsiveness in allergic guinea pigs in vivo using the PreciseInhale system for delivery of dry powder aerosols.

Authors:  A J Lexmond; S Keir; W Terakosolphan; C P Page; B Forbes
Journal:  Drug Deliv Transl Res       Date:  2018-06       Impact factor: 4.617

Review 6.  Modifying and Integrating in vitro and ex vivo Respiratory Models for Inhalation Drug Screening.

Authors:  Aylin Cidem; Peta Bradbury; Daniela Traini; Hui Xin Ong
Journal:  Front Bioeng Biotechnol       Date:  2020-10-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.